Recent News for ALPN - Alpine Immune Sciences, Inc.

Date Title
Jun 23 Introducing Alpine Immune Sciences (NASDAQ:ALPN), The Stock That Dropped 43% In The Last Year
Jun 23 Investors Who Bought Alpine Immune Sciences (NASDAQ:ALPN) Shares A Year Ago Are Now Down 43%
Jun 20 Alpine Immune Sciences (ALPN) Investor Presentation - Slideshow
Jun 3 Alpine Immune Sciences Appoints Biopharma Veteran Wayne Gombotz as Chief Technology Officer
May 24 Kite exits research collaboration with Alpine
May 24 Alpine Immune Sciences to Present at Upcoming Investor Conferences
May 15 AdaptImmune partners to advance promising cancer immunotherapies
May 15 Adaptimmune teams up with Alpine to develop next-gen cell therapies
May 15 Adaptimmune and Alpine Immune Sciences Announce Collaboration and License Agreement to Develop Next-Generation SPEAR T-Cell Products
May 9 Alpine Immune Sciences misses by $0.01
May 6 Earnings Preview: Alpine Immune Sciences (ALPN) Q1 Earnings Expected to Decline
Apr 24 Have Insiders Been Buying Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Shares?
Apr 18 Alpine Immune Sciences Appoints Stanford Peng to President and Head of Research and Development
Apr 11 The Zacks Analyst Blog Highlights: CMS Energy, Alpine Immune Sciences, Kohl's, Franklin Resources and Dominion Energy
Apr 10 5 Best Stocks to Buy Ahead of Q1 Earnings Season
Apr 5 Will Nivalis Therapeutics Continue to Surge Higher?
Apr 4 The Zacks Analyst Blog Highlights: Alpine, Actinium, Molecular Templates, Tricida and Otonomy
Apr 3 Small Drugmakers Outperforming the Bigshots: 7 Stocks to Buy
Mar 18 Alpine Immune Sciences misses by $0.01, misses on revenue
Mar 18 Alpine Immune Sciences Provides Corporate Update and Reports Full Year 2018 Financial Results
Mar 15 Top Ranked Momentum Stocks to Buy for March 15th
Mar 12 Alpine Immune Sciences (ALPN) Presents At Cowen And Company 39th Annual Health Care Conference - Slideshow
Mar 8 Alpine Immune Sciences: A New Name On The Radar
Mar 7 Diving Into Biotech With BioSci Capital Partners (Podcast)
Feb 19 Alpine Immune Sciences Presents Preclinical ALPN-101 GvHD Data at the 2019 Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR (TCT Meetings)
Back to the Main ALPN Page...